Ireland· IE-PA-PA2219/007/002
Albunorm 20%, 200g/l, solution for infusion
A albumin product containing human plasma protein not containing less than 96% human albumin, registered in Ireland by Octapharma (IP). The same ATC class is registered in 13 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Albumin is registered in 13 of 19 countries.
Countries holding a registration under ATC B05AA01 (albumin), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 8 of them publish a price we can compare per daily dose
Albumin · ATC B05AA01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Human plasma protein not containing less than 96% human albumin
- Manufacturer
- Octapharma (IP)
- Country
- Ireland (IE)
- ATC code
- B05AA01
- ATC class
- Albumin
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA2219/007/002
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under B05AA01
Albumin, as other registers publish it.
- FinlandAlbiominBiotest Pharma GmbH
- PolandAlbiomin 20%Biotest Pharma GmbH
- IcelandAlbumanProthya Biosolutions Netherlands B.V.
- FinlandAlbumanProthya Biosolutions Netherlands B.V.
- FinlandAlbumanProthya Biosolutions Netherlands B.V.
- NetherlandsAlbuman 200 g/l oplossing voor infusieProthya Biosolutions Netherlands B.V.
- NetherlandsAlbuman 40 g/l oplossing voor infusieProthya Biosolutions Netherlands B.V.
- DenmarkAlbumin "Baxalta"Baxalta Innovations GmbH
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/395aea8c-a705-459a-986e-d17d18d87059 GET /v1/drugs/395aea8c-a705-459a-986e-d17d18d87059?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for infusion",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"B05AA",
"B05AA01"
],
"strength": null,
"pa_number": "PA2219/007/002",
"substances": [
"Human plasma protein not containing less than 96% human albumin"
],
"legal_basis": "New active substance (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "25/06/2009",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about albumin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.